Contribuciones a la investigación en Medicina Antroposófica – 2024

Autor correspondiente:

Publicado: 16.04.2024

Fuentes de investigación


  1. Büttner R, Schwermer M, Ostermann T, Längler A, Zuzak T. Expert consensus-based clinical recommendation for an integrative anthroposophic treatment approach to acute tonsillitis in childhood. Complementary Therapies in Medicine 2024;81:103031. DOI:
  2. Dombrowsky C, Klein S,Würtenberger S, Baumgartner S, Tournier A. Theorien und Modelle zum Wirkprinzip potenzierter Arzneimittel – ein Scoping-Review. Posterabstract. Der Merkurstab 2024;77(1):44. DOI:
  3. Fahrentrapp J, Baumgartner S, Würtenberger S, Kokornaczyk MO. Systematische Untersuchung von Kombinationen pflanzlicher und mineralischer Tiefpotenzen anhand der Tropfenverdunstungsmethode. Posterabstract. Der Merkurstab 2024;77(2):125. DOI:
  4. Gerlach K. Holistic movement therapy in allergic rhinitis: A 45-year-old female treated with eurythmy therapy sequence TSRMA. Posterabstract. Der Merkurstab 2024;77(2):128-12. DOI:
  5. Gerlach K, Mehl A, Kröz M, Trapp B, Pretzer K, von Laue HB. Revision of a validated peer-report questionnaire to assess assessment of Eurythmy Therapy: AART-ASSESS EuMove: An expert consensus process. Posterabstract. Der Merkurstab 2024;77(1):45-46. DOI:
  6. Ghelman R, Hosomi JK, Schveitzer MC, Schlechta Portella CF, de Araújo, Rodrigues AM, Lenk EJ, Garcia da Costa, EM, Alves Oliveira GS, Baldissin MM, Gardin NE, de Oliveira Vieira PM, Volkmann PR, Takeda M, Mendes, Abdala CV. Clinical effectivity of the anthroposophic medicine: a CABSIN evidence map. Posterabstract. Der Merkurstab 2024;77(2):124. DOI:
  7. Grande S, Batista J, Melo MNO, Souza MR, Holandino C, Baumgartner S. Topical use of Viscum album hydrogel in rheumatoid arthritis: a case report. Posterabstract. Der Merkurstab 2024;77(2):126. DOI:
  8. Hancock M, Ketterl P, Vinas X, Werthmann PG. Case cluster of RT-PCR COVID-19 positive patients with an unexpected benign clinical course with vitamin D, melatonin, vitamin C, and Viscum album. Der Merkurstab 2024;77(1):9-12. DOI:
  9. Hellhammer J, Spitznagel-Schminke L, Hufnagel R. Kalium phosphoricum comp. in patients with neurasthenia: a randomized, double-blind, placebo-controlled clinical trial. Current Medical Research and Opinion 2024;40(2):239-251. DOI:
  10. Huber T, Krüerke D, Simões-Wüst AP. How physicians and nursing staff perceive effectiveness and tolerability of Bryophyllum preparations: an online survey in an anthroposophic hospital. Complementary Medicine Research 2024. DOI:
  11. Kiene H, Hamre HJ. A Fundamental Question for Complementary Medicine: Are There Other Forces in the Natural World Besides the Physical Forces? Complementary Medicine Research 2024;31(1):71-77. DOI:
  12. Künne R, Baumgartner S, Heusser P, Würtenberger S. Kann Hahnemanns Konzept einer geistartigen Wirkung potenzierter Substanzen Bestandteil der heutigen wissenschaftlichen Diskussion sein? Posterabstract. Der Merkurstab 2024;77(2):126-127. DOI:
  13. Lederer AK, Rieger S, Schink M, Huber R. Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects. Pharmaceuticals 2024;17(3):278. DOI:
  14. Maier M, Piqué-Borràs MR, Schmelzer S, Röhrl J, Nausch L. Assessing how an herbal multicomponent medicine for digestive disorders interacts with the growth of selected intestinal bacteria. Posterabstract. Der Merkurstab 2024;77(2):125. DOI:
  15. Piqué-Borràs MR, Röhrl J, Künstle G. The underlying molecular mechanisms of two herbal compound mixtures in sleeprelated disorders. Posterabstract. Der Merkurstab 2024;77(2):127. DOI:
  16. Piqué-Borràs MR, Röhrl J, Künstle G. Potential molecular mechanism of Bryophyllum pinnatum preparations in the management of various hyperactive disorders. Posterabstract. Der Merkurstab 2024;77(2):127. DOI:
  17. Röhrl J, Piqué-Borràs MR, Künstle G. In vitro studies highlight the potent anti-inflammatory capabilities of the hydroethanolic Arnicae flos extract. Posterabstract. Der Merkurstab 2024;77(2):127-128. DOI:
  18. Sousa JM, do Nascimento AX, Miglio AA, Melo MMS, da Silva RSM, de Souza VT, de Sousa VLM. Challenges for anthroposophic nursing – a reflecting essay. Posterabstract. Der Merkurstab 2024;77(1):46-47. DOI:
  19. Sparby T, Cysarz D, Hornemann V Laer D, Edelhäuser F, Tauschel D, Weger UW. The phenomenology of attentional control: a first-person approach to contemplative science and the issue of free will. Frontiers in Psychology 2024;15:1349826. DOI:
  20. Szöke H, Kocsis T; Nyul Z; Mészner Z; Fekete F; Ráfis JH; Vagedes J; Szijjártó L; Szőke R; Verzár Z; Balogh A. Association Between Applying a Mobile Health Decision Aid and Education Application and Caregivers' Behavioral Change in the Management of Child Febrile Illnesses - Use of Antibiotics, Antipyretics, and the Healthcare System: A Single-Arm Prospective Pre-Post Intervention Study. Currently submitted to: JMIR mHealth and uHealth 2024; DOI:
  21. Ücker A, Baumgartner S, Martin D, Jäger T. Reagieren Arsen-geschädigte Wasserlinsen auf potenzierte Präparate? Eine kritische Evaluation. Posterabstract. Der Merkurstab 2024;77(1):47. DOI:
  22. Vagedes J, Huber BM, Islam MOA, Vagedes K, Kohl M, Schoen-Angerer TV. Antibiotic Use in a Neonatal Intensive Care Unit Practicing Integrative Medicine-A Retrospective Analysis. Journal of Integrative and Complementary Medicine 2024;30(4) 394-402. DOI:
  23. Weissenstein U, Leonhard B, Baumgartner S. A fermented mistletoe extract elicits endoplasmic reticulum stress driven immunogenic cell death in breast cancer and melanoma cells. Posterabstract. Der Merkurstab 2024;77(1):47-48. DOI:
  24. Winnubst ME, da Silva CC, Santos GC, Ferraz HB, Borges V. Evaluation of the effects of medical painting therapy in patients with essential tremor. Posterabstract. Der Merkurstab 2024;77(1):48. DOI:
  25. Zilkowski I, Herrick A, Stintzing FC. Application and safety of three anthroposophic eye drop preparations for treatment of inflamed eyes – results of two retrospective surveys. Posterabstract. Der Merkurstab 2024;77(1):48-49. DOI:

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degreee of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. These findings may underline the clinical impact of add-on VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers: